Clinical Outcomes and Characteristics of Patients (pts) with FLT3–Internal Tandem Duplication (FLT3-ITD)–Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Undergoing Hematopoietic Stem Cell Transplant (HSCT) after Quizartinib (Q) or Salvage Chemotherapy (SC) in the Quantum-R Trial | Zendy

Siddhartha Ganguly | Zendy; Jorge E. Cortés | Zendy; Alwin Krämer | Zendy; Mark J. Levis | Zendy; Giovanni Martinelli | Zendy; Alexander E. Perl | Zendy; Nigel H. Russell | Zendy; Meena Arunachalam | Zendy; Guy Gammon | Zendy; Arnaud Lesegretain | Zendy; Derek E. Mires | Zendy; Samer K. Khaled | Zendy

Open Access

Clinical Outcomes and Characteristics of Patients (pts) with FLT3–Internal Tandem Duplication (FLT3-ITD)–Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Undergoing Hematopoietic Stem Cell Transplant (HSCT) after Quizartinib (Q) or Salvage Chemotherapy (SC) in the Quantum-R Trial

Author(s) -

Siddhartha Ganguly,

Jorge E. Cortés,

Alwin Krämer,

Mark J. Levis,

Giovanni Martinelli,

Alexander E. Perl,

Nigel H. Russell,

Meena Arunachalam,

Guy Gammon,

Arnaud Lesegretain,

Derek E. Mires,

Samer K. Khaled

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.071

Subject(s) - medicine , myeloid leukemia , refractory (planetary science) , hematopoietic stem cell transplantation , oncology , haematopoiesis , stem cell , hematopoietic stem cell , cancer research , transplantation , genetics , physics , astrobiology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research